Clinical Trial

Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development

Study acronym: LATENT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Our study aimed to use an AF-predict AI-ECG alert system to help physicians identify patients who need to wear a continuous cardiac rhythm monitor for new diagnoses of atrial fibrillation (AF), atrial flutter (AFL), or atrial arrhythmia with high AF risk, including premature atrial complexes (PAC) ≥ 500/24hr, burst PACs \> 20 beats, non-sustained AF/AFL.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-02-21; most recent amendment 2025-11-16.
Status change: Not Yet Recruiting → Recruiting 2025-11-16
Trial Details
NCT Number NCT06847932
Lead Sponsor National Defense Medical Center, Taiwan
Conditions Atrial Fibrillation (AF), Premature Atrial Complexes, Atrial Arrhythmias, Artificial Intelligence (AI), Electrocardiogram
Enrollment 14,726 participants
Start Date 2025-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-19